Literature DB >> 33982292

Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma.

M Claeson1,2,3, P Baade4,5, M Marchetti6, S Brown1,2, H P Soyer2,7, B M Smithers8, A C Green1,9, D C Whiteman1, K Khosrotehrani2,7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33982292      PMCID： PMC8492480          DOI： 10.1111/bjd.20480

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   11.113


× No keyword cloud information.
  8 in total

1.  Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?

Authors:  Michael A Marchetti; Edmund K Bartlett; Stephen W Dusza; Christopher K Bichakjian
Journal:  J Am Acad Dermatol       Date:  2018-12-23       Impact factor: 11.527

2.  Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma.

Authors:  M Claeson; P Baade; S Brown; H P Soyer; B M Smithers; A C Green; D C Whiteman; K Khosrotehrani
Journal:  Br J Dermatol       Date:  2019-11-24       Impact factor: 9.302

3.  Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.

Authors:  Evan Stiegel; David Xiong; Jason Ya; Pauline Funchain; Raymond Isakov; Brian Gastman; Alok Vij
Journal:  J Am Acad Dermatol       Date:  2018-01-31       Impact factor: 11.527

4.  More people die from thin melanomas (⩽1 mm) than from thick melanomas (>4 mm) in Queensland, Australia.

Authors:  David C Whiteman; Peter D Baade; Catherine M Olsen
Journal:  J Invest Dermatol       Date:  2014-10-20       Impact factor: 8.551

5.  Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

Authors:  Dale Han; Jonathan S Zager; Yu Shyr; Heidi Chen; Lynne D Berry; Sanjana Iyengar; Mia Djulbegovic; Jaimie L Weber; Suroosh S Marzban; Vernon K Sondak; Jane L Messina; John T Vetto; Richard L White; Barbara Pockaj; Nicola Mozzillo; Kim James Charney; Eli Avisar; Robert Krouse; Mohammed Kashani-Sabet; Stanley P Leong
Journal:  J Clin Oncol       Date:  2013-11-04       Impact factor: 44.544

6.  Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.

Authors:  Phyllis A Gimotty; David E Elder; Douglas L Fraker; Jeffrey Botbyl; Kimberly Sellers; Rosalie Elenitsas; Michael E Ming; Lynn Schuchter; Francis R Spitz; Brian J Czerniecki; DuPont Guerry
Journal:  J Clin Oncol       Date:  2007-03-20       Impact factor: 44.544

7.  Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria.

Authors:  Brian R Gastman; Pedram Gerami; Sarah J Kurley; Robert W Cook; Sancy Leachman; John T Vetto
Journal:  J Am Acad Dermatol       Date:  2018-08-04       Impact factor: 11.527

8.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702
  8 in total
  1 in total

1.  Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.

Authors:  Annabel Meireson; Liesbeth Ferdinande; Marc Haspeslagh; Benjamin Hennart; Delphine Allorge; Piet Ost; Nora Sundahl; Mathieu Spaas; Annelies Demeyer; Lieve Brochez
Journal:  Front Immunol       Date:  2021-09-07       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.